About SymbioCellTech

About company

SymbioCellTech is a biotechnology start-up that has developed a patented, proprietary therapy to cure insulin-dependent Type I diabetes Mellitus (T1DM), which is commonly referred to as Type 1 or juvenile onset diabetes.